Yousefi S, Higgins E, Daoling Z, Pollex-Krüger A, Hindsgaul O, Dennis J W
Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto, Ontario, Canada.
J Biol Chem. 1991 Jan 25;266(3):1772-82.
Malignant transformation of rodent cell lines by polyoma virus and by activated ras genes is associated with increased UDP-GlcNAc:Man alpha-R beta-1,6-N-acetylglucosaminyltransferase V (GlcNAc-transferase V) activity and it product -GlcNAc beta 1-6Man alpha 1-6Man beta 1-branched Asn-linked oligosaccharides. In this report, we have compared beta 1-6GlcNAc branching of core O- and N-linked oligosaccharides in three experimental models of malignancy, namely (a) rat2 fibroblasts and their malignant T24H-ras-transfected counterpart; (b) benign SP1 mammary carcinoma cells and two metastic sublines of SP1; and (c) the metastatic MDAY-D2 lymphoma cell line and its poorly metastatic glycosylation mutant KBL-1. In addition to the previously reported increase in GlcNAc-transferase V activity, UDP-GlcNAc:Gal beta 1-3GalNAc alpha-R (GlcNAc to GalNAc) beta-1,6-N-acetylglucosaminyltransferase (core 2 GlcNAc-transferase, EC 2.4.1.102) activity was found to be elevated by 70% in the malignant rat2 and SP1 cell lines while several other glycosyltransferase activities were not significantly different. The action of core 2 GlcNAc-transferase followed by beta 1-4Gal-transferase provides an N-acetyllactosamine antenna that can be extended with polylactosamine (i.e. repeating Gal beta 1-4GlcNAc beta 1-3) provided UDP-GlcNAc:Gal beta-R beta 1-3GlcNAc-transferase (GlcNAc-transferase) (i)) activity is present. Polylactosamine content in microsomal membrane glycoproteins was quantitated by labeling the GlcNAc termini resulting from the action of Escherichia freundii endo-beta-galactosidase with bovine galactosyltransferase/UDP-[3H] Gal. Glycopeptidase F- sensitive and -insensitive fractions were measured to assess the N- and O-linked components. In the SP1 tumor model, the metastatic sublines showed increased core 2 GlcNAc-transferase and GlcNAc-transferase V activities but no change in GlcNAc-transferase (i) activity, yet polylactosamine was increased in both O- and N-linked oligosaccharides. In rat2 cells, down-regulation of GlcNAc-transferase (i) following transformation was associated with decreased polyactosamine even though core 2 GlcNAc-transferase and GlcNAc-transferase V were elevated in the cells. Finally, a 3-fold decrease in GlcNAc-transferase V in KBL-1, the glycosylation mutant of MDAY-D2 cells, resulted in complete loss of polylactosamine in N-linked but no change in O-linked polylactosamine content. These results suggest that, provided GlcNAc-transferase (i) is not limiting, the beta 1-6-branching enzymes core 2 GlcNAc-transferase and GlcNAc-transferase V regulate the levels of polyactosamine in O- and N-linked oligosaccharides, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)
多瘤病毒和激活的ras基因使啮齿动物细胞系发生恶性转化,这与UDP - GlcNAc:Manα - Rβ - 1,6 - N - 乙酰葡糖胺基转移酶V(GlcNAc - 转移酶V)活性及其产物——GlcNAcβ1 - 6Manα1 - 6Manβ1分支的天冬酰胺连接寡糖增加有关。在本报告中,我们比较了三种恶性肿瘤实验模型中核心O - 连接和N - 连接寡糖的β1 - 6GlcNAc分支情况,即:(a)大鼠2成纤维细胞及其经恶性T24H - ras转染的对应细胞;(b)良性SP1乳腺癌细胞以及SP1的两个转移亚系;(c)转移性MDAY - D2淋巴瘤细胞系及其转移能力较差的糖基化突变体KBL - 1。除了先前报道的GlcNAc - 转移酶V活性增加外,还发现UDP - GlcNAc:Galβ1 - 3GalNAcα - R(GlcNAc到GalNAc)β - 1,6 - N - 乙酰葡糖胺基转移酶(核心2 GlcNAc - 转移酶,EC 2.4.1.102)活性在恶性大鼠2和SP1细胞系中升高了70%,而其他几种糖基转移酶活性没有显著差异。核心2 GlcNAc - 转移酶随后作用于β1 - 4Gal - 转移酶,可提供一个N - 乙酰乳糖胺天线,若存在UDP - GlcNAc:Galβ - Rβ1 - 3GlcNAc - 转移酶(GlcNAc - 转移酶(i))活性,该天线可被聚乳糖胺(即重复的Galβ1 - 4GlcNAcβ1 - 3)延长。通过用牛半乳糖基转移酶/UDP - [3H]Gal标记弗氏埃希菌内切β - 半乳糖苷酶作用产生的GlcNAc末端,对微粒体膜糖蛋白中的聚乳糖胺含量进行定量。测量糖肽酶F敏感和不敏感部分以评估N - 连接和O - 连接成分。在SP1肿瘤模型中,转移亚系显示核心2 GlcNAc - 转移酶和GlcNAc - 转移酶V活性增加,但GlcNAc - 转移酶(i)活性没有变化,然而O - 连接和N - 连接寡糖中的聚乳糖胺均增加。在大鼠2细胞中,转化后GlcNAc - 转移酶(i)的下调与聚乳糖胺减少有关,尽管细胞中核心2 GlcNAc - 转移酶和GlcNAc - 转移酶V升高。最后,MDAY - D2细胞的糖基化突变体KBL - l中GlcNAc - 转移酶V降低了3倍,导致N - 连接的聚乳糖胺完全丧失,但O - 连接的聚乳糖胺含量没有变化。这些结果表明,若GlcNAc - 转移酶(i)不是限制因素,β1 - 6分支酶核心2 GlcNAc - 转移酶和GlcNAc - 转移酶V分别调节O - 连接和N - 连接寡糖中聚乳糖胺的水平。(摘要截短至400字)